ReviewClinical and translational science2026
Drug-Drug Interaction Risk Assessment Strategies for Biologics in Inflammatory Bowel Disease: A Literature-Based Evidence Mini-Review.
Claire Steinbronn et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.